Skip to main content

BioCommunique Article

Bringing you the latest financial and strategic news from top leaders in life science over the past two weeks.

Twist Bioscience and LakePharma team up on antibody services, Alexandria Real Estate launches inaugural class of seed- and early-stage life science companies at Alexandria LaunchLabs, Illumina to parse ancient DNA

  • 2019-04-11T19:52:00.000+0000
  • California
  • Author: Lauren Panetta

4/10/19 – FierceBiotech
Twist Bioscience, LakePharma pair for antibody services

4/10/19 – Scientist.com
Scientist.com and antibodies-online.com Launch Product Hub, a One-Stop-Shop for Antibodies, ELISA Kits and Proteins

4/10/19 – Biospace
Alexandria LaunchLabs Grants First Seed Capital to Holobiome in Cambridge

4/10/19 – OncoSec
OncoSec Announces New Technology to Treat Deep Visceral Lesions with IL-12

4/9/19 – Daré Bioscience
Daré Bioscience, Inc. Prices Underwritten Public Offering of Common Stock

4/9/19 – FierceBiotech
Pfizer signs Concerto to apply real-world data to targeted drugs

4/9/19 – Endpoints
Celgene, Acceleron submit FDA application for billed blockbuster luspatercept — will they get priority review?

4/9/19 – Endpoints
UPDATED: Once spurned, Amgen wins the FDA over with its bone-building osteoporosis drug Evenity

4/9/19 – Biospace
AbbVie Takes Top Spot in Best Place to Work Survey

4/8/19 – Turning Point Therapeutics
Turning Point Therapeutics Appoints Annette North as Executive Vice President and General Counsel

4/8/19 – Oncolytics
Oncolytics Biotech® Announces First Patient Treated in Company's AWARE-1 Window of Opportunity Study of Pelareorep in Breast Cancer

4/5/19 – NuVasive
NuVasive Lessray® Platform Wins Top Honor At 2019 Edison Awards

4/5/19 – Trovagene
Trovagene Announces Update to Phase 1b/2 AML Trial Data Presented at AACR

4/4/19 – Genome Web
Inscripta Expands Series C Financing Round to $105.5M

4/4/19 – Forbes
Verily's OneFifteen Promises Self-Learning Healthcare

4/1/19 – Endpoints
It’s a seller’s world in biotech M&A, and Novartis CEO Vas Narasimhan has his check book out and pen ready

3/28/19 – FierceBiotech
Astellas, Seattle plan FDA filing after cancer ADC clears test

3/26/19 – FierceBiotech
Illumina to parse ancient DNA to find how brain disorders began

4/8/19 – Endpoints
After revamping R&D in a global shakeup, Bayer prepping new labs for an expansion in cancer research at MIT